Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Equity (2016 - 2025)

Historic Return on Equity for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to 0.13%.

  • Anika Therapeutics' Return on Equity fell 700.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.26% for FY2024, which is 600.0% up from last year.
  • Per Anika Therapeutics' latest filing, its Return on Equity stood at 0.13% for Q3 2025, which was down 700.0% from 0.32% recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Return on Equity registered a high of 0.05% during Q2 2024, and its lowest value of 0.32% during Q2 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.03% (2022), whereas its average is 0.07%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 1100bps in 2021, then tumbled by -3700bps in 2025.
  • Anika Therapeutics' Return on Equity (Quarter) stood at 0.02% in 2021, then plummeted by -98bps to 0.0% in 2022, then crashed by -2667bps to 0.01% in 2023, then tumbled by -1917bps to 0.28% in 2024, then skyrocketed by 55bps to 0.13% in 2025.
  • Its Return on Equity stands at 0.13% for Q3 2025, versus 0.32% for Q2 2025 and 0.3% for Q1 2025.